» Articles » PMID: 24681487

Loss of the M-AAA Protease Subunit AFG₃L₂ Causes Mitochondrial Transport Defects and Tau Hyperphosphorylation

Overview
Journal EMBO J
Date 2014 Apr 1
PMID 24681487
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

The m-AAA protease subunit AFG₃L₂ is involved in degradation and processing of substrates in the inner mitochondrial membrane. Mutations in AFG₃L₂ are associated with spinocerebellar ataxia SCA28 in humans and impair axonal development and neuronal survival in mice. The loss of AFG₃L₂ causes fragmentation of the mitochondrial network. However, the pathogenic mechanism of neurodegeneration in the absence of AFG₃L₂ is still unclear. Here, we show that depletion of AFG₃L₂ leads to a specific defect of anterograde transport of mitochondria in murine cortical neurons. We observe similar transport deficiencies upon loss of AFG₃L₂ in OMA1-deficient neurons, indicating that they are not caused by OMA1-mediated degradation of the dynamin-like GTPase OPA1 and inhibition of mitochondrial fusion. Treatment of neurons with antioxidants, such as N-acetylcysteine or vitamin E, or decreasing tau levels in axons restored mitochondrial transport in AFG₃L₂-depleted neurons. Consistently, tau hyperphosphorylation and activation of ERK kinases are detected in mouse neurons postnatally deleted for Afg3l2. We propose that reactive oxygen species signaling leads to cytoskeletal modifications that impair mitochondrial transport in neurons lacking AFG₃L₂.

Citing Articles

Screening of mitochondrial-related biomarkers connected with immune infiltration for acute respiratory distress syndrome through WGCNA and machine learning.

Sun W, Tu S Medicine (Baltimore). 2025; 104(10):e41497.

PMID: 40068062 PMC: 11903030. DOI: 10.1097/MD.0000000000041497.


Multi-omics-based phenotyping of AFG3L2-mutant lymphoblasts determines key factors of a pathophysiological interplay between mitochondrial vulnerability and neurodegeneration in spastic ataxia type 5.

Oeztuerk M, Herebian D, Dipali K, Hentschel A, Rademacher N, Kraft F Front Mol Neurosci. 2025; 18:1548255.

PMID: 40051915 PMC: 11882581. DOI: 10.3389/fnmol.2025.1548255.


Mitochondrial quality control in human health and disease.

Liu B, Xu C, Liu Y, Lu Z, Fu T, Li G Mil Med Res. 2024; 11(1):32.

PMID: 38812059 PMC: 11134732. DOI: 10.1186/s40779-024-00536-5.


Mitochondrial protein synthesis quality control.

Koludarova L, Battersby B Hum Mol Genet. 2024; 33(R1):R53-R60.

PMID: 38280230 PMC: 11112378. DOI: 10.1093/hmg/ddae012.


Multifaceted Roles of AFG3L2, a Mitochondrial ATPase in Relation to Neurological Disorders.

Ghosh Dastidar R, Banerjee S, Lal P, Ghosh Dastidar S Mol Neurobiol. 2023; 61(7):3788-3808.

PMID: 38012514 PMC: 11236935. DOI: 10.1007/s12035-023-03768-z.


References
1.
Falzone T, Stokin G, Lillo C, Rodrigues E, Westerman E, Williams D . Axonal stress kinase activation and tau misbehavior induced by kinesin-1 transport defects. J Neurosci. 2009; 29(18):5758-67. PMC: 3849468. DOI: 10.1523/JNEUROSCI.0780-09.2009. View

2.
Reddy P, Tripathi R, Troung Q, Tirumala K, Reddy T, Anekonda V . Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. Biochim Biophys Acta. 2011; 1822(5):639-49. PMC: 3272314. DOI: 10.1016/j.bbadis.2011.10.011. View

3.
Twig G, Elorza A, Molina A, Mohamed H, Wikstrom J, Walzer G . Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 2008; 27(2):433-46. PMC: 2234339. DOI: 10.1038/sj.emboj.7601963. View

4.
Baker M, Lampe P, Stojanovski D, Korwitz A, Anand R, Tatsuta T . Stress-induced OMA1 activation and autocatalytic turnover regulate OPA1-dependent mitochondrial dynamics. EMBO J. 2014; 33(6):578-93. PMC: 3989652. DOI: 10.1002/embj.201386474. View

5.
Ohsawa I, Nishimaki K, Murakami Y, Suzuki Y, Ishikawa M, Ohta S . Age-dependent neurodegeneration accompanying memory loss in transgenic mice defective in mitochondrial aldehyde dehydrogenase 2 activity. J Neurosci. 2008; 28(24):6239-49. PMC: 6670537. DOI: 10.1523/JNEUROSCI.4956-07.2008. View